BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 11232499)

  • 21. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of endoscopic method in treatment of strictures of biliary tree].
    Wojtuń S; Gil J; Zyśko B
    Pol Merkur Lekarski; 2007 May; 22(131):477-81. PubMed ID: 17679400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive familial intrahepatic cholestasis.
    Mirza R; Abbas Z; Luck NH; Azam SM; Aziz S; Hassan SM; Soomro GB
    J Coll Physicians Surg Pak; 2006 Oct; 16(10):673-5. PubMed ID: 17007761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
    Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP
    Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive familial intrahepatic cholestasis.
    Cavestro GM; Frulloni L; Cerati E; Ribeiro LA; Corrente V; Sianesi M; Franzè A; Di Mario F
    Acta Biomed; 2002; 73(3-4):53-6. PubMed ID: 12596388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary sclerosing cholangitis--diagnosis and therapy].
    Virović L; Supanc V; Duvnjak M
    Acta Med Croatica; 2003; 57(3):207-19. PubMed ID: 14582467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
    Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
    J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrahepatic cholestasis].
    Adachi Y; Kamisako T
    Nihon Rinsho; 1996 Mar; 54(3):788-93. PubMed ID: 8904238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benign recurrent intrahepatic cholestasis type-II--a rare cause of direct hyperbilirubinemia exacerbations with hepatic fibrosis].
    Mizrahi M; Lalazar G; Horwich Y; Adar T; Safadi R
    Harefuah; 2008 May; 147(5):381-3, 480. PubMed ID: 18770956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of intrahepatic cholestasis syndrome].
    Kraus MR; Scheurlen M
    MMW Fortschr Med; 2004 Jun; 146(23):34-7. PubMed ID: 15373130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intrahepatic cholestasis due to biochemical errors of bile acids. II. Clinical and therapeutic aspects].
    Lovisetto P; Raviolo P
    Minerva Med; 1994 Dec; 85(12):639-46. PubMed ID: 7854557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary sclerosing cholangitis.
    Alba LM; Angulo P; Lindor KD
    Minerva Gastroenterol Dietol; 2002 Jun; 48(2):99-113. PubMed ID: 16489301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cholestasis and cholestatic liver diseases].
    Poupon R
    Gastroenterol Clin Biol; 2009; 33(8-9):778-88. PubMed ID: 19556086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.